A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Investigator(s):
Organization:
UCLA
NCT Number:
Disease Name:
X-linked Chronic Granulomatous Disease (X-CGD)
Disease Category:
Trial Phases:
Phase 1/2
Trial Status:
Recruiting

Dr. Caroline Kuo (left) and Dr. Donald Kohn
Trial Contact:
Caroline Kuo, M.D.
(310) 825-6481
ckuo@mednet.ucla.edu